← Open Payments lookup

ZAYNAB SAID: Open Payments

NPI 1568047512 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$807 in 44 payments from 16 companies in 2025. Trend: 2023 $1,057 · 2024 $750 · 2025 $807

Food & beverage: $807
CompanyPaymentsAmount
ABBVIE INC.13$221
Novo Nordisk Inc6$116
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$109
Otsuka America Pharmaceutical, Inc.2$47
Janssen Pharmaceuticals, Inc2$44
AstraZeneca Pharmaceuticals LP2$38
Lilly USA, LLC2$35
Astellas Pharma US Inc1$33
Axsome Therapeutics, Inc.2$31
Kowa Pharmaceuticals America, Inc.2$30

Products named: VRAYLAR, CAPLYTA, REXULTI, SPRAVATO, Ozempic, Wegovy, UBRELVY, Veozah.

Industry payments across IA — which companies pay providers there.